Moreover, mutations altering pathways involved in prostate carcinogenesis including FOXA1‐, SPOP‐ and ATM‐regulated signals could be useful to discover new therapeutic targets for the treatment of metastatic PCa. This evidence concerns the gene ATM and posterior cortical atrophy.